SARS-CoV-2 tropism in the brain and its relationship to COVID-19 pathogenesis
SARS-CoV-2 tropism in the brain and its relationship to COVID-19 pathogenesis
批准号:
10272724
负责人:
ERIC D LAZARTIGUES
金额:
$64.26万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-25 至 2023-08-31
关键词:
2019-nCoVACE2AddressAdenovirus InfectionsAffectAmericanAnimal ModelAutomobile DrivingBiochemicalBrainBrain StemCOVID-19COVID-19 pandemicCOVID-19 pathogenesisCOVID-19 patientCell NucleusCessation of lifeCountryDataDeliriumDisastersDiseaseEncephalopathiesEndothelial CellsFiberFunding MechanismsHallucinationsHistologicHumanImpairmentIndividualInfectionInjectionsKnowledgeLabelLaboratoriesLeadLungLung infectionsMainstreamingMechanical ventilationMethodsMicrogliaMolecularMotor CortexMusNeurobiologyNeurogliaNeurologic SymptomsNeuronsNeurosciencesNeurotropismOrganOrganoidsPathogenesisPatientsPhotometryPneumoniaRNARecoveryRegulationReportingResearchResistanceRespirationRespiratory FailureRespiratory distressRespiratory physiologyResuscitationRiskRoleRouteSARS coronavirusSARS-CoV-2 infectionSARS-CoV-2 pathogenesisSmell PerceptionTaste PerceptionTestingTissuesTransgenic MiceTropismViral PathogenesisVirusassociated symptombetacoronaviruscell typeeffective therapyhigh rewardhigh riskin vivoinnovationinsightmental statemind controlmortalitymouse modelneuroinflammationneuron lossnovelolfactory bulboptogeneticspathogenpromoterreceptorrespiration regulationrespiratoryrespiratory virustherapeutic targetvirology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
COVID-19 is a US and global disaster which has led to the deaths of almost a million
individuals, including over 203,000 Americans, thus far. COVID-19 is caused by a novel
beta-coronavirus (CoV) known as Severe Acute Respiratory Syndrome (SARS)-CoV-2,
which was reported to cause severe pneumonia and lethal respiratory failure. Little is
known about the disease mechanism of this virus and its disease mechanism. In this
application, we propose to test the effects of SARS-CoV-2 on the brain. We will develop
multiple cell-type specific mouse models that express the SARS-CoV-2 receptor, human
ACE2, in a cell-type specific manner. We will then use a variety of molecular,
biochemical, histological and neuroscience approaches to test the brain tropism of
SARS-CoV-2 in depth and the effects of that on the central regulation of respiration.
This proposal will have a transformative impact on our current understanding of COVID-
19 and its mechanisms of pathogenesis and will uncover important therapeutic targets.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting ADAM17 maturation in resistant hypertension.
-
批准号:10608153
-
项目类别:
-
资助金额:$54.93万
-
财政年份:2022
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Targeting ADAM17 maturation in resistant hypertension.
-
批准号:10432585
-
项目类别:
-
资助金额:$57.83万
-
财政年份:2022
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
COVID19: SARS-CoV-2 and ACE2 interaction in hypertension
-
批准号:10152313
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
COVID19: SARS-CoV-2 and ACE2 interaction in hypertension
-
批准号:10398819
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Targeting ACE2 ubiquitination for hypertension
-
批准号:10318183
-
项目类别:
-
资助金额:$60.05万
-
财政年份:2019
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Targeting ACE2 ubiquitination for hypertension
-
批准号:10534148
-
项目类别:
-
资助金额:$60.05万
-
财政年份:2019
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
New strategies to restore ACE2 compensatory activity in neurogenic hypertension
-
批准号:10266017
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Effects of ACE2 gene therapy on Diabetes
-
批准号:7895432
-
项目类别:
-
资助金额:$20.21万
-
财政年份:2010
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Effects of ACE2 gene therapy on Diabetes
-
批准号:8102099
-
项目类别:
-
资助金额:$16.82万
-
财政年份:2010
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
P7: BRAIN-TARGETED ACE2 OVEREXPRESSION AND BLOOD PRESSURE REGULATION
-
批准号:7959748
-
项目类别:
-
资助金额:$5.55万
-
财政年份:2009
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Brain-targeted ACE2 over-expression on angiotensin-II-mediated hypertension
-
批准号:7834552
-
项目类别:
-
资助金额:$16.81万
-
财政年份:2009
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Brain-targeted ACE2 over-expression on angiotensin-II-mediated hypertension
-
批准号:8289581
-
项目类别:
-
资助金额:$35.15万
-
财政年份:2008
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Mechanisms of ACE2 Regulation in Neurogenic Hypertension
-
批准号:8772578
-
项目类别:
-
资助金额:$37.58万
-
财政年份:2008
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
P7: BRAIN-TARGETED ACE2 OVEREXPRESSION AND BLOOD PRESSURE REGULATION
-
批准号:7720715
-
项目类别:
-
资助金额:$16.93万
-
财政年份:2008
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Brain-targeted ACE2 over-expression on angiotensin-II-mediated hypertension
-
批准号:8116621
-
项目类别:
-
资助金额:$35.5万
-
财政年份:2008
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Mechanisms of ACE2 Regulation in Neurogenic Hypertension
-
批准号:9111971
-
项目类别:
-
资助金额:$37.58万
-
财政年份:2008
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Mechanisms of ACE2 Regulation in Neurogenic Hypertension
-
批准号:9269608
-
项目类别:
-
资助金额:$37.58万
-
财政年份:2008
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Brain-targeted ACE2 over-expression on angiotensin-II-mediated hypertension
-
批准号:7655265
-
项目类别:
-
资助金额:$35.5万
-
财政年份:2008
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
Brain-targeted ACE2 over-expression on angiotensin-II-mediated hypertension
-
批准号:7900354
-
项目类别:
-
资助金额:$35.5万
-
财政年份:2008
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
P7: BRAIN-TARGETED ACE2 OVEREXPRESSION AND BLOOD PRESSURE REGULATION
-
批准号:7610601
-
项目类别:
-
资助金额:$20.69万
-
财政年份:2007
-
负责人:ERIC D LAZARTIGUES
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ACE2/AGXT2信号轴在甲基异柳磷诱导斑马鱼神经发育异常过程中的作用机制研究
-
批准号:JCZRLH202600625
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
ACE2 Ser623磷酸化调控MED1促VSMCs功能损伤在移植血管重构中的作用及机制研究
-
批准号:2026JJ50619
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:翁春艳
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2细胞受体识别及其分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
铁皮石斛通过肠道 ACE2 修复 Trp/GPR142 介
导“肠-胰岛 ”轴血糖调控功能的降糖机制研
究
-
批准号:Y24H280055
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:颜美秋
-
依托单位:
人类ACE2变构抑制剂的成药性及其抗广谱冠状病毒感染的机制研究
-
批准号:82330111
-
项目类别:重点项目
-
资助金额:220万元
-
批准年份:2023
-
负责人:刘刚
-
依托单位:
CAFs来源的外泌体负性调控ACE2促进肾透明细胞癌癌栓新辅助靶向耐药的机制研究
-
批准号:82373169
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:顾良友
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2受体识别及细胞入侵机制研究
-
批准号:32300137
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈静
-
依托单位:
基于外泌体miRNAs介导细胞通讯的大豆ACE2激活肽调控血管稳态机制研究
-
批准号:32302080
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:宋田源
-
依托单位:
基于AT2/ACE2/Ang(1-7)/MAS轴调控心脏-血管-血液系统性重构演变规律研究心衰气虚血瘀证及其益气通脉活血化瘀治法生物学基础
-
批准号:82305216
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:姚骏凯
-
依托单位:
感毒清经ACE2/Ang(1-7)/MasR信号通路抑制PM2.5诱导慢性气道炎症的机制:聚焦肺泡巨噬细胞极化与“胞葬”的表型串扰
-
批准号:82305171
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:吴永灿
-
依托单位: